Preparation and characterization of protein C-loaded PLA nanoparticles

Journal of Controlled Release

Volumn 60, Issue 2-3, 1999, Pages 179-188

  Zambaux, M F ^a   Bonneaux, F ^a   Gref, R ^b,c   Dellacherie, E ^b   Vigneron, C ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b LAB DE CHIM PHYS MACROMOLECULAIRE   (France)

^c UNIV PARIS SUD   (France)

Author keywords

Biodegradable nanoparticles; Poly(lactic acid); Protein C; Protein delivery; Protein stability

Indexed keywords

HUMAN SERUM ALBUMIN; METHANOL; NANOPARTICLE; POLYLACTIC ACID; POLYVINYL ALCOHOL; PROTEIN C;

ANTIGENICITY; ARTICLE; BLOOD CLOTTING TIME; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; EMULSION; ENCAPSULATION; IN VITRO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; TECHNIQUE;

ANTICOAGULANTS; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; HUMANS; LACTIC ACID; METHYLENE CHLORIDE; MICROSPHERES; PARTICLE SIZE; POLYMERS; POLYVINYL ALCOHOL; PROTEIN C; SONICATION; SURFACE-ACTIVE AGENTS;

EID: 0032765725     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00073-5     Document Type: Article

References (26)

1. Guillin M.C. Le système de la protéine C. Presse Méd. 16:(10):1987;468-470.
2. Horellou M.H., Conard J., Van Dreden P., Samama M. Protéine C et implications cliniques. Hématologie. 35:(29):1985;1749-1756.
3. Taylor F.B., Chang A., Esmon C.T., D'angelo A., Vigano-D'Angelo S., Blick K.E. Protein C prevents the coagulopathic and lethal effects of E. Coli infusion in the baboon. J. Clin. Invest. 79:1987;918-925.
4. Vincenot A., Gaussem P. Physiologie et régulation cellulaire du système de la protéine C. Ann. Biol. Clin. 55:1997;17-24.
5. Marlar R.A., Kressin D.D., Madden R.M. Contribution of plasma protease inhibitors to the regulation of activated protein C in plasma. Thromb. Haemost. 69:1993;16-20.
6. Zambaux M.F., Bonneaux F., Dellacherie E. Covalent fixation of soluble derivatized dextrans to model proteins in low-concentration medium: application to factor IX and protein C. J. Prot. Chem. 17:(3):1998;279-284.
7. Couvreur P. Vecteurs nanoparticulaires de médicaments. Buri P., Puisieux F., Doelker E., Benoit J.P. Formes Pharmaceutiques Nouvelles, Aspects technologique, biopharmaceutique et médical. 1985;577-611 Lavoisier, Tec. et Doc, Paris.
8. Niven R.W., Ip A.Y., Mittelman S., Prestrelski S.J., Arakawa T. Some factors associated with the ultrasonic nebulization of proteins. Pharm. Res. 12:(1):1995;53-59.
9. Park T.G., Lu W., Crotts G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J. Control. Release. 33:1995;211-222.
10. P.P. DeLuca, F. Rypacek, Preparation of biodegradable microspheres useful as carriers for macromolecules, US Patent no. 4741872, 1988.
11. Huang L.K., Mehta R.C., DeLuca P.P. Evaluation of a statistical model for the formation of poly(acryloyl hydroxyethyl starch) microspheres. Pharm. Res. 14:(4):1997;475-482.
12. Zambaux M.F., Bonneaux F., Gref R., Maincent P., Dellacherie E., Alonso M.J., Labrude P., Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J. Control. Release. 50:1998;31-40.
13. Müller R.H. Colloidal Carriers for Controlled Drug Delivery and Targeting. 1991;45-46 CRC Press, Boca Raton, FL.
14. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:1977;346-356.
15. Gander B., Wehrl E., Alder R., Merkle H.P. Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. J. Microencapsulation. 12:1995;83-97.
16. Scopes R. Protein Purification: Principles and Practice. 2nd ed :1984;Springer-Verlag, New York, Heidelberg, Berlin.
17. P. Quellec, Nanosphères furtives à base de copolymères biodégradables pour la libération contrôlée de principes actifs hydrophobes et de protéines, Thesis, Nancy, France, November 1997.
18. Belbella A., Vauthier C., Fessi H., Devissaguet J.P., Puisieux F. In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities. Int. J. Pharm. 129:1996;95-102.
19. Bodmeier R., Oh K.H., Chen H. The effect of the addition of low molecular weight poly(D,L-lactide) on drug release from biodegradable poly(D,L-lactide) drug delivery systems. Int. J. Pharm. 51:1989;1-8.
20. Song C.X., Labshasetwar V., Murphy H., Qu X., Humphrey W.R., Shebuski R.J., Levy R.J. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J. Control. Release. 43:1997;197-212.
21. Blanco M.D., Alonso M.J. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur. J. Pharm. Biopharm. 43:1997;287-294.
22. Verrecchia T., Huve P., Bazile D., Veillard M., Spenlehauer G., Couvreur P. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. J. Biomed. Mater. Res. 27:1993;1019-1028.
23. Crotts G., Park T.G. Stability and release of bovine serum albumin encapsulated within poly(D,L-lactide-co-glycolide) microparticles. J. Control. Release. 44:1997;123-134.
24. Verrechia T., Spenlehauer G., Bazile D.V., Murry-Brelier A., Archimbaud Y., Veillard M. Non-stealth (poly(lactic acid: albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J. Control. Release. 36:1995;49-61.
25. Fernandez-Urrusuno R., Fattal E., Rodrigues Jr J.M., Féger J., Bedossa P., Couvreur P. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. J. Biomed. Mater. Res. 31:1996;401-408.
26. Storm G., Belliot S.O., Daemen T., Lasic D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug Del. Rev. 17:1995;31-48.